Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
71%
OVERLAP
BY WEIGHT
59
# OF OVERLAPPING
HOLDINGS
VHT
422
HOLDINGS
15%
ALSO IN IXJ
IXJ
114
HOLDINGS
57%
ALSO IN VHT
SECTOR DRIFT (VHT minus IXJ)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in VHT |
Weight in IXJ |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 12.7% | 9.7% | 9.7% |
|
JOHNSON & JOHNSON | 9.0% | 7.1% | 7.1% |
|
ABBVIE INC | 6.3% | 4.9% | 4.9% |
|
MERCK & CO. INC. | 5.1% | 4.5% | 4.5% |
|
UNITEDHEALTH GROUP INC | 5.0% | 3.9% | 3.9% |
VHT Overweight Relative to IXJ
|
ELI LILLY & CO | 3.0% |
|
JOHNSON & JOHNSON | 1.9% |
|
ABBVIE INC | 1.4% |
|
UNITEDHEALTH GROUP INC | 1.1% |
|
MERCK & CO. INC. | 0.6% |
|
NATERA INC | 0.6% |
|
ALNYLAM PHARMACEUTICALS INC | 0.5% |
|
REVOLUTION MEDICINES, INC. | 0.5% |
|
ILLUMINA INC | 0.4% |
|
AMGEN INC | 0.4% |
VHT Underweight Relative to IXJ
 |
NOVARTIS AG | -3.5% |
 |
ASTRAZENECA PLC | -3.0% |
 |
NOVO NORDISK A/S-B | -1.8% |
|
GSK PLC | -1.2% |
 |
SANOFI-AVENTIS | -1.1% |
 |
ARGEN-X SE | -0.8% |
 |
CSL LIMITED | -0.7% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -0.7% |
 |
BAYER AG | -0.7% |
|
ESSILOR INTERNATIONAL | -0.6% |